Stay updated on Teriflunomide in Pediatric MS Clinical Trial

Sign up to get notified when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Teriflunomide in Pediatric MS Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Removed the core topic 'Multiple sclerosis' and the related topics section 'MedlinePlus Genetics' from the page.
    Difference
    0.1%
    Check dated 2026-02-23T15:49:48.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added related topics for Multiple sclerosis and MedlinePlus Genetics, and updated the site revision from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-16T15:56:15.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Addition of site Revision: v3.4.1 and removal of the funding-status notice along with Revision: v3.4.0. These updates reflect routine site maintenance and do not affect the study data or eligibility.
    Difference
    0.3%
    Check dated 2026-02-09T12:23:12.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Added: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0; Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-26T09:59:56.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added: Revision: v3.3.4. Deleted: 'Multiple sclerosis' and 'MedlinePlus Genetics' related topics and the 'Revision: v3.3.3' note.
    Difference
    0.1%
    Check dated 2026-01-19T07:45:31.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added topic tags such as Multiple sclerosis and MedlinePlus Genetics and expanded Locations with Alabama, Florida, Massachusetts, North Carolina, Alberta, and London, plus updated the revision to v3.3.3; removed HHS Vulnerability Disclosure and several specific Location entries (e.g., Alabama Locations, Florida Locations, Massachusetts Locations, North Carolina Locations, Alberta Locations, London, City of Locations).
    Difference
    0.6%
    Check dated 2025-12-22T01:39:28.000Z thumbnail image

Stay in the know with updates to Teriflunomide in Pediatric MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.